Daniel Hargbøl Madsen

[CCIT-DK: National Center for Cancer Immune Therapy @CCITdk]

New study from the TSMI group led at @CCITdk by @DanielHMadsen potential repurposing of beta-blockers as #cancer drugs! In Fjæstad et al. propranolol inhibits #tumor growth in mice and enhances #Immunotherapy. Support @lundbeckfonden @cancer_dk

[CCIT-DK: National Center for Cancer Immune Therapy @CCITdk]

Postdoctoral position!
The Tumor-Stroma Matrix Immunology (TSMI) group led by @DanielHMadsen is seeking a postdoctoral researcher, to investigate the influence of the #tumor microenvironment/extracellular matrix on #immunotherapy. Click here https://t.co/lCyKvIgia8 #sciencejobs